OBESITY OR OVERWEIGHT
Clinical trials for OBESITY OR OVERWEIGHT explained in plain language.
Never miss a new study
Get alerted when new OBESITY OR OVERWEIGHT trials appear
Sign up with your email to follow new studies for OBESITY OR OVERWEIGHT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy targets gut disease and obesity together
Disease control Recruiting nowThis phase 3 trial tests whether adding tirzepatide (a weight-loss drug) to mirikizumab (an anti-inflammatory drug) helps people with moderate-to-severe ulcerative colitis who are also overweight or obese. The goal is to see if the combination can reduce both gut symptoms and bod…
Matched conditions: OBESITY OR OVERWEIGHT
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New weekly shot shows promise for major weight loss in major trial
Disease control Recruiting nowThis phase 3 trial is testing a new weekly injection called enicepatide for weight loss in 2000 adults with obesity or overweight who do not have type 2 diabetes. Participants will receive either the drug or a placebo for 72 weeks. The main goal is to see how much weight they los…
Matched conditions: OBESITY OR OVERWEIGHT
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New weekly shot could help obese diabetics shed pounds and control blood sugar
Disease control Recruiting nowThis Phase 3 trial is testing a new weekly injection called enicepatide for weight loss in 1600 people who are obese or overweight and also have type 2 diabetes. The drug works by mimicking natural hormones that help control appetite and blood sugar. Participants will receive eit…
Matched conditions: OBESITY OR OVERWEIGHT
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Can a Weight-Loss drug boost Crohn's treatment? new trial aims to find out
Disease control Recruiting nowThis study tests whether adding the weight-loss drug tirzepatide to the Crohn's drug mirikizumab helps people with moderate-to-severe Crohn's disease who are also overweight or have obesity. About 290 adults will receive either mirikizumab alone or mirikizumab plus tirzepatide. T…
Matched conditions: OBESITY OR OVERWEIGHT
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New obesity drug aims to help keep weight off after switching from popular injections
Disease control Recruiting nowThis phase 3 trial tests whether switching from common GLP-1 weight-loss drugs to a new medication called maridebart cafraglutide can help adults with obesity or overweight maintain their weight loss. About 300 participants who have already lost at least 10% of their body weight …
Matched conditions: OBESITY OR OVERWEIGHT
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New obesity drug GZR18 under microscope: how does it interact with common meds?
Disease control Recruiting nowThis early-stage study tests GZR18, an injectable drug for obesity or overweight, in 60 Chinese adults. Researchers want to see how it affects stomach emptying and whether it changes how the body processes digoxin (heart medication), rosuvastatin (cholesterol drug), and warfarin …
Matched conditions: OBESITY OR OVERWEIGHT
Phase: PHASE1 • Sponsor: Gan & Lee Pharmaceuticals. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC